Literature DB >> 29742053

Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.

Orso Maria Lucherini1, Donato Rigante2, Jurgen Sota1, Claudia Fabiani3, Laura Obici4, Marco Cattalini5, Marco Gattorno6, Luca Cantarini7.   

Abstract

An apparently unprovoked recurrent inflammation is the quintessential hallmark of autoinflammatory diseases (AIDs), a large and heterogeneous group of disorders in which there is poor regulation of the innate immune system with no clearly demonstrated autoimmune machinery involvement. Innate immunity pathways are diverse and our understanding of their molecular composition and function is continuously expanding. The impaired immune responses we observe in monogenic AIDs, mostly in the hereditary periodic fever syndromes, is officiated by target molecules of microbial origin (pathogen-associated molecular patterns) and also host molecules (danger-associated molecular patterns). Further crucial components of innate immune mechanisms that contribute differently in the deregulated inflammatory patterns of different AIDs include Toll-like receptors, Nod-like receptors, scaffolding proteins (such as the caspase recruitment domain of proteins), cytosolic DNA-sensing molecules, inflammatory multi-protein complexes (referred to as inflammasomes), complement system, and others. In recent years, the knowledge of protean molecular pathways responsible for the most common monogenic AIDs has expanded, in parallel with very recent extraordinary technological advances, allowing the identification and characterisation of some unknown aspects of the innate immunity. This review will list and describe the most common monogenic febrile syndromes belonging to AIDs and will focus on current insights dealing with their pathologic processes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29742053

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

Review 1.  Autoinflammatory Disease-Associated Vasculitis/Vasculopathy.

Authors:  Mansour Alghamdi
Journal:  Curr Rheumatol Rep       Date:  2018-11-17       Impact factor: 4.592

2.  An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells.

Authors:  Ekaterina V Vinogradova; Xiaoyu Zhang; David Remillard; Daniel C Lazar; Radu M Suciu; Yujia Wang; Giulia Bianco; Yu Yamashita; Vincent M Crowley; Michael A Schafroth; Minoru Yokoyama; David B Konrad; Kenneth M Lum; Gabriel M Simon; Esther K Kemper; Michael R Lazear; Sifei Yin; Megan M Blewett; Melissa M Dix; Nhan Nguyen; Maxim N Shokhirev; Emily N Chin; Luke L Lairson; Bruno Melillo; Stuart L Schreiber; Stefano Forli; John R Teijaro; Benjamin F Cravatt
Journal:  Cell       Date:  2020-07-29       Impact factor: 41.582

Review 3.  Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases.

Authors:  Kleopatra Deuteraiou; George Kitas; Alexandros Garyfallos; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2018-06-04       Impact factor: 2.631

Review 4.  The Broad-Ranging Panorama of Systemic Autoinflammatory Disorders with Specific Focus on Acute Painful Symptoms and Hematologic Manifestations in Children.

Authors:  Donato Rigante
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

Review 5.  Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans.

Authors:  Raffaele Manna; Donato Rigante
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-05-01       Impact factor: 3.122

Review 6.  How Should We Classify Kawasaki Disease?

Authors:  Edoardo Marrani; Jane C Burns; Rolando Cimaz
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 7.  Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.

Authors:  Mehmet Soy; Gökhan Keser; Pamir Atagündüz; Fehmi Tabak; Işık Atagündüz; Servet Kayhan
Journal:  Clin Rheumatol       Date:  2020-05-30       Impact factor: 2.980

Review 8.  Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.

Authors:  Zahra Bahari; Zohreh Jangravi; Hassan Ghoshooni; Mohammad Reza Afarinesh; Gholam Hossein Meftahi
Journal:  Inflamm Res       Date:  2021-02-19       Impact factor: 4.575

9.  Behçet's Syndrome in a Chinese Pedigree of NLRP3-Associated Autoinflammatory Disease: A Coexistence or Novel Presentation?

Authors:  Jinjing Liu; Xin Yu; Chaoran Li; Yi Wang; Weihong Yu; Min Shen; Wenjie Zheng
Journal:  Front Med (Lausanne)       Date:  2021-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.